<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04041583</url>
  </required_header>
  <id_info>
    <org_study_id>2019H0015</org_study_id>
    <nct_id>NCT04041583</nct_id>
  </id_info>
  <brief_title>Clinical and Radiological Outcomes of Posterior Cervical Fusion Supplemented With Interfacet Spacers</brief_title>
  <official_title>Clinical and Radiological Outcomes of Posterior Cervical Fusion Supplemented With Interfacet Spacers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective study to assess fusion rates and cervical sagittal parameters following&#xD;
      posterior cervical arthrodesis procedures supplemented with CIS. Data will be collected from&#xD;
      medical records for up to 730 days after surgery. Data to be collected will be demographic,&#xD;
      preoperative clinical information, surgical details, and radiographic information. Patients&#xD;
      will also undergo a non-standard of care CT scan 2 years after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and Rationale&#xD;
&#xD;
      Posterior cervical fusion surgeries are performed for degenerative cervical conditions,&#xD;
      cervical deformity, cervical tumors, and cervical trauma. They are preferred over an anterior&#xD;
      approach when the pathology is located posterior to the spinal cord or when multiple levels&#xD;
      must be addressed. Degenerative cervical spondylosis contributes to loss of disc height,&#xD;
      facet arthropathy and hypertrophy, and retrolisthesis of the vertebral bodies, all of which&#xD;
      can lead to foraminal stenosis, or narrowing around the exiting nerve roots. This is often&#xD;
      accompanied by loss of cervical lordosis. During a posterior fusion operation, the&#xD;
      restoration of cervical lordosis can worsen this foraminal stenosis and lead to iatrogenic&#xD;
      radiculopathy with and estimated incidence between 2.4-50%. Cadaveric studies have shown the&#xD;
      insertion of interfacet spacers in the cervical spine increase foraminal height, and serve to&#xD;
      indirectly decompress the exiting nerve roots. Another common complication of cervical spine&#xD;
      surgery is C5 palsy, which has been reported in 4.6% of patient undergoing posterior cervical&#xD;
      spine decompressive procedures, including decompression and fusion. Patients suffering from&#xD;
      iatrogenic C5 palsy have significantly increased recovery times, and often require additional&#xD;
      services such as imaging studies (CT, MRI) and increased need for physical and occupational&#xD;
      therapy, thus increasing costs. Given the ability to decompress the neuroforamen with&#xD;
      interfacet spacers, they could potentially be an effective technique for reducing the&#xD;
      incidence of C5 palsy.&#xD;
&#xD;
      The use of cervical interfacet spacers (CIS; CORNERSTONE Facet MicroGrafts, Medtronic,&#xD;
      Minneapolis, MN) is a relatively novel technique shown to be useful for posterior fusion to&#xD;
      address symptomatic pseudoarthrosis (fusion failure) after anterior cervical arthrodesis. CIS&#xD;
      have a relatively large osteoconductive surface area and are placed under tension in the&#xD;
      interfacet space, which together favorably influence bony fusion. Current techniques for&#xD;
      posterior cervical fusion rely on graft placement using bone extenders placed in the&#xD;
      posterolateral space, which is not under a compressive load. Wolfe's law dictates that&#xD;
      certain amounts of loading of bone grafts is required to achieve bony fusion. Therefore, the&#xD;
      use of CIS could potentially increase fusion rates after posterior cervical arthrodesis&#xD;
      procedures and reduce or eliminate the need for use of bone graft extenders. Reassuringly,&#xD;
      radiologic studies have shown that despite the increase in foraminal height, the use of CIS&#xD;
      does not lead to loss of cervical lordosis.&#xD;
&#xD;
      Study Objective&#xD;
&#xD;
      To date, there have been no prospective studies examining the use of cervical interfacet&#xD;
      spacers. The investigators propose to undertake a prospective study to assess fusion rates&#xD;
      and cervical sagittal parameters following posterior cervical arthrodesis procedures&#xD;
      supplemented with CIS.&#xD;
&#xD;
      Primary Outcome Measures The primary outcome measures will include (i) the rate of cervical&#xD;
      fusion measured on post-operative radiographs and CT scans performed at 2-years and (ii)&#xD;
      cervical sagittal alignment parameters as measured on post-operative radiographs.&#xD;
&#xD;
      Secondary Outcome Measures The secondary outcome measures will include post-operative patient&#xD;
      reported outcomes including NRS, NDI, and SF-36 RAND. As well, all neurological adverse&#xD;
      events will be prospectively collected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cervical Fusion</measure>
    <time_frame>2-Years</time_frame>
    <description>Cervical Fusion Measured on Post-Operative Radiographs and CT scans</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cervical Sagittal Alignment Parameters</measure>
    <time_frame>2-Years</time_frame>
    <description>Cervical Sagittal Alignment Parameters measured on post-operative radiographs</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>NRS</measure>
    <time_frame>2-Years</time_frame>
    <description>Numerical Rating Score for Pain from 0-10 where lower values represent a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NDI</measure>
    <time_frame>2-Years</time_frame>
    <description>Neck Disability Index from 0-100% where lower values represent a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 RAND</measure>
    <time_frame>2-Years</time_frame>
    <description>Quality of Life Measures from 0-100 where higher values represent a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Adverse Events</measure>
    <time_frame>2-Years</time_frame>
    <description>Adverse Events</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Cervical Fusion</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <description>Patients undergoing posterior cervical arthrodesis procedures for spondylosis supplemented with CIS involving three or more segmental levels in the subaxial cervicothoracic spine (between C2-upper thoracic)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cervical Interfacet Spacers</intervention_name>
    <description>The use of Cervical Interfacet Spacers is a relatively novel technique shown to be useful for posterior fusion to address symptomatic pseudoarthrosis (fusion failure) after anterior cervical arthrodesis [2]. CIS have a relatively large osteoconductive surface area and are placed under tension in the interfacet space, which together favorably influence bony fusion [2].</description>
    <arm_group_label>Arm 1</arm_group_label>
    <other_name>(CIS; CORNERSTONE Facet MicroGrafts, Medtronic, Minneapolis, MN)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing posterior cervical arthrodesis procedures for spondylosis supplemented&#xD;
        with CIS involving three or more segmental levels in the subaxial cervicothoracic spine&#xD;
        (between C2-upper thoracic)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  â‰¥ 18 years old&#xD;
&#xD;
          -  Symptomatic multi-level degenerative spondylosis necessitating posterior cervical&#xD;
             arthrodesis in the subaxial cervicothoracic spine (between C2-upper thoracic).&#xD;
&#xD;
          -  Surgery performed within the Department of Neurological Surgery at The Ohio State&#xD;
             University Wexner Medical Center (OSUWMC)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Traumatic injury&#xD;
&#xD;
          -  Co-morbidity requiring medication use that may interfere with bone or soft tissue&#xD;
             healing (i.e., high dose oral or parenteral glucocorticoids, immunosuppressive agents,&#xD;
             methotrexate) - at discretion of investigator&#xD;
&#xD;
          -  Severe co-morbidities (e.g., heart, respiratory, or renal disease)&#xD;
&#xD;
          -  Recent (&lt;3 yrs) or co-incident spinal tumor or infection&#xD;
&#xD;
          -  Concurrent involvement in another investigational drug or device study that could&#xD;
             confound study data&#xD;
&#xD;
          -  History of substance abuse (recreational drugs, prescription drugs or alcohol) that&#xD;
             could interfere with protocol assessments and/or with the subject's ability to&#xD;
             complete the protocol required follow-up&#xD;
&#xD;
          -  Subjects who are pregnant or plan to become pregnant in the next 24 months&#xD;
&#xD;
          -  Prisoner&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Grossbach, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Ohio State University Wexner Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy J Minnema, MS</last_name>
    <phone>614-685-9827</phone>
    <email>amy.minnema@osumc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy J Minnema, MS</last_name>
      <phone>614-685-9827</phone>
      <email>amy.minnema@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Andrew Grossbach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Tan LA, Gerard CS, Anderson PA, Traynelis VC. Effect of machined interfacet allograft spacers on cervical foraminal height and area. J Neurosurg Spine. 2014 Feb;20(2):178-82. doi: 10.3171/2013.11.SPINE131. Epub 2013 Dec 13. Erratum in: J Neurosurg Spine. 2014 Jun;20(6):772.</citation>
    <PMID>24328759</PMID>
  </results_reference>
  <results_reference>
    <citation>Kasliwal MK, Corley JA, Traynelis VC. Posterior Cervical Fusion Using Cervical Interfacet Spacers in Patients With Symptomatic Cervical Pseudarthrosis. Neurosurgery. 2016 May;78(5):661-8. doi: 10.1227/NEU.0000000000001087.</citation>
    <PMID>26516824</PMID>
  </results_reference>
  <results_reference>
    <citation>Mummaneni PV, Meyer SA, Wu JC. Biological approaches to spinal instrumentation and fusion in spinal deformity surgery. Clin Neurosurg. 2011;58:110-6.</citation>
    <PMID>21916134</PMID>
  </results_reference>
  <results_reference>
    <citation>Tan LA, Straus DC, Traynelis VC. Cervical interfacet spacers and maintenance of cervical lordosis. J Neurosurg Spine. 2015 May;22(5):466-9. doi: 10.3171/2014.10.SPINE14192. Epub 2015 Feb 13.</citation>
    <PMID>25679233</PMID>
  </results_reference>
  <results_reference>
    <citation>Fogel GR, Toohey JS, Neidre A, Brantigan JW. Fusion assessment of posterior lumbar interbody fusion using radiolucent cages: X-ray films and helical computed tomography scans compared with surgical exploration of fusion. Spine J. 2008 Jul-Aug;8(4):570-7. Epub 2007 May 29.</citation>
    <PMID>17544854</PMID>
  </results_reference>
  <results_reference>
    <citation>Turel MK, Kerolus MG, Traynelis VC. Machined cervical interfacet allograft spacers for the management of atlantoaxial instability. J Craniovertebr Junction Spine. 2017 Oct-Dec;8(4):332-337. doi: 10.4103/jcvjs.JCVJS_87_17.</citation>
    <PMID>29403245</PMID>
  </results_reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 23, 2019</study_first_submitted>
  <study_first_submitted_qc>July 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2019</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Andrew Grossbach</investigator_full_name>
    <investigator_title>Principal Investigator, Assistant Clinical Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 22, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/83/NCT04041583/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

